News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,739 Results
Type
Article (1640)
Company Profile (5)
Press Release (38093)
Section
Business (16398)
Career Advice (82)
Deals (2121)
Drug Delivery (1)
Drug Development (4909)
Employer Resources (1)
FDA (669)
Job Trends (819)
News (23300)
Policy (1196)
Tag
Academia (41)
Accelerated approval (3)
Allergies (8)
Alliances (1195)
ALS (6)
Alzheimer's disease (77)
Antibody-drug conjugate (ADC) (22)
Approvals (718)
Artificial intelligence (8)
Autoimmune disease (14)
Automation (1)
Bankruptcy (7)
Best Places to Work (782)
BIOSECURE Act (2)
Biosimilars (8)
Biotechnology (3)
Bladder cancer (11)
Brain cancer (4)
Breast cancer (47)
Cancer (330)
Cardiovascular disease (25)
Career advice (82)
CAR-T (12)
Cell therapy (29)
Cervical cancer (2)
Clinical research (4669)
Collaboration (51)
Compensation (20)
Complete response letters (5)
COVID-19 (73)
CRISPR (6)
C-suite (10)
Cystic fibrosis (7)
Data (637)
Depression (11)
Dermatology (10)
Diabetes (50)
Diagnostics (280)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (7)
Drug pricing (2)
Drug shortages (2)
Duchenne muscular dystrophy (16)
Earnings (15746)
Editorial (2)
Employer resources (1)
Events (6301)
Executive appointments (10)
FDA (1007)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (30)
Gene editing (11)
Generative AI (1)
Gene therapy (33)
GLP-1 (49)
Government (118)
Guidances (164)
Healthcare (882)
HIV (2)
Huntington's disease (2)
IgA nephropathy (7)
Immunology and inflammation (15)
Immuno-oncology (2)
Indications (13)
Infectious disease (87)
Inflammatory bowel disease (8)
Influenza (7)
Intellectual property (11)
Interviews (14)
IPO (1499)
IRA (1)
Job creations (94)
Job search strategy (60)
JPM (3)
Layoffs (9)
Leadership (1)
Legal (168)
Liver cancer (6)
Lung cancer (59)
Lymphoma (41)
Manufacturing (22)
MASH (22)
Medical device (744)
Medtech (748)
Mergers & acquisitions (641)
Metabolic disorders (109)
mRNA (8)
Multiple sclerosis (13)
NASH (2)
Neurodegenerative disease (15)
Neuropsychiatric disorders (9)
Neuroscience (176)
NextGen: Class of 2026 (179)
Non-profit (93)
Obesity (38)
Opinion (6)
Ovarian cancer (10)
Pain (16)
Pancreatic cancer (13)
Parkinson's disease (22)
Partnered (1)
Patents (18)
Patient recruitment (24)
Peanut (1)
People (949)
Pharmaceutical (4)
Pharmacy benefit managers (2)
Phase 1 (971)
Phase 2 (2083)
Phase 3 (1911)
Pipeline (975)
Policy (8)
Postmarket research (186)
Preclinical (475)
Press Release (4)
Prostate cancer (22)
Psychedelics (3)
Radiopharmaceuticals (18)
Rare diseases (59)
Real estate (147)
Recruiting (1)
Regulatory (1148)
Reports (3)
Research institute (48)
Resumes & cover letters (8)
RSV (5)
Schizophrenia (26)
Series A (5)
Series B (2)
Sickle cell disease (15)
Special edition (1)
Spinal muscular atrophy (9)
Sponsored (1)
Startups (79)
Stomach cancer (2)
Supply chain (3)
Tariffs (1)
The Weekly (3)
Vaccines (36)
Weight loss (17)
Women's health (8)
Date
Today (1)
Last 7 days (62)
Last 30 days (217)
Last 365 days (2357)
2026 (601)
2025 (2369)
2024 (2516)
2023 (2864)
2022 (3228)
2021 (3915)
2020 (2600)
2019 (2170)
2018 (1481)
2017 (1300)
2016 (998)
2015 (1310)
2014 (910)
2013 (519)
2012 (610)
2011 (796)
2010 (682)
Location
Africa (24)
Alabama (3)
Arizona (12)
Arkansas (1)
Asia (2473)
Australia (286)
California (899)
Canada (204)
China (79)
Colorado (41)
Connecticut (38)
Delaware (35)
Europe (5330)
Florida (108)
Georgia (37)
Idaho (1)
Illinois (70)
India (1)
Indiana (79)
Japan (56)
Kansas (1)
Kentucky (6)
Louisiana (7)
Maine (12)
Maryland (120)
Massachusetts (617)
Michigan (22)
Minnesota (71)
Missouri (6)
Montana (2)
Nebraska (2)
Nevada (4)
New Hampshire (10)
New Jersey (350)
New York (237)
North Carolina (90)
Northern California (486)
Ohio (17)
Oklahoma (1)
Pennsylvania (217)
South America (61)
South Carolina (1)
Southern California (346)
Tennessee (13)
Texas (114)
United States (3284)
Utah (36)
Virginia (10)
Washington D.C. (3)
Washington State (68)
Wisconsin (8)
39,739 Results for "111".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coya Therapeutics Announces $11.1 Million Private Placement
February 1, 2026
·
8 min read
Press Releases
Ultragenyx Announces U.S. FDA Acceptance of BLA Resubmission for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
April 2, 2026
·
7 min read
Press Releases
Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
March 15, 2026
·
10 min read
Press Releases
111, Inc. Announces Third Quarter 2025 Unaudited Financial Results
December 17, 2025
·
22 min read
Press Releases
RISA Labs Closes $11.1M Series A to Scale AI Operating System for Oncology Nationwide
January 14, 2026
·
4 min read
Press Releases
Ultragenyx Resubmits Biologics License Application for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA) to U.S. FDA
February 1, 2026
·
8 min read
Press Releases
PDS Biotechnology Announces up to $11.1 Million Registered Direct Offering
November 11, 2025
·
8 min read
Press Releases
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
December 5, 2025
·
6 min read
Press Releases
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
September 17, 2025
·
20 min read
Press Releases
Ultragenyx Announces Positive Longer-Term Data Demonstrating Treatment with UX111 Gene Therapy Results in Sustained, Significant Reductions in CSF-HS and Continued Meaningful Improvements in Clinical Function Across Multiple Developmental Domains in Children with Sanfilippo Syndrome (MPS IIIA)
February 3, 2026
·
10 min read
1 of 3,974
Next
